OCLN and Anxiety: EA may downregulate EGC-derived GSNO expressions, repair the intestinal barrier by upregulating ZO-1 and occludin, restore intestinal homeostasis, and eventually relieve IBS-D symptoms such as visceral hypersensitivity, anxiety, and diarrhea (Figure 1).